Dissecting the role of the Nijmegen breakage syndrome protein in SHH-dependent tumorigenesis

Anno
2020
Proponente Giuseppe Giannini - Professore Ordinario
Sottosettore ERC del proponente del progetto
LS4_6
Componenti gruppo di ricerca
Componente Categoria
Rocco Palermo Componenti strutturati del gruppo di ricerca / Structured participants in the research project
Elisabetta Ferretti Componenti strutturati del gruppo di ricerca / Structured participants in the research project
Francesca Fabretti Dottorando/Assegnista/Specializzando componente non strutturato del gruppo di ricerca / PhD/Assegnista/Specializzando member non structured of the research group
Gianluca Canettieri Componenti strutturati del gruppo di ricerca / Structured participants in the research project
Laura Di Magno Dottorando/Assegnista/Specializzando componente non strutturato del gruppo di ricerca / PhD/Assegnista/Specializzando member non structured of the research group
Saula Checquolo Componenti strutturati del gruppo di ricerca / Structured participants in the research project
Componente Qualifica Struttura Categoria
Francesca Belardinilli Borsista Dip. Medicina Molecolare Altro personale aggregato Sapienza o esterni, titolari di borse di studio di ricerca / Other aggregate personnel Sapienza or other institution, holders of research scholarships
De Panfilis Simone Scientist Istituto Italiano Tecnologia Altro personale aggregato Sapienza o esterni, titolari di borse di studio di ricerca / Other aggregate personnel Sapienza or other institution, holders of research scholarships
Abstract

Development of the cerebellum is exquisitely dependent on the Sonic Hedgehog (SHH) pathway that drives the expansion of granule cell progenitors (GCPs) and other cells. Impairment of this pathway leads to cerebellar hypoplasia. On the opposite, its untimely/excessive activation results in medulloblastoma development, supporting the oncogenic role of the pathway. SHH signal transduction largely occurs in the primary cilium (PC), an antenna-like structure enriched in receptors and other signaling molecules. This is organized by the basal body in non-mitotic cells. After PC disassembly, the same organelle organizes the centrosome, before mitotic onset. Dysfunctions of this dynamic organelle affect SHH pathway and are involved in genetic diseases known as ciliopathies, in CNS developmental diseases and cancer.
Nbs1 is a member of the Mre11/Rad50/Nbs1 complex, which is essential for genome integrity and the DNA damage response. Mutations in the Nbs1 gene cause the Nijmegen Breakage syndrome, a DDR-defective syndrome characterized by immunodeficiency, microcephaly and cancer predisposition.
Taking advantage of a CNS restricted Nbs1 knock-out mouse model, we recently demonstrated that Nbs1-KO abrogates tumorigenesis in a spontaneous model of SHH-MB and impairs the growth of SHH-MB allografts. Inducible Nbs1-KO inhibits the SHH-pathway in developing GCPs, in vivo and in vitro. Hints from the literature and our preliminary data suggest that Nbs1 may exert previously unrecognized functions on the PC, thus affecting SHH-dependent cerebellar development and tumorigenesis.
In this project we will develop new animal and cellular models to specifically address this hypothesis and we will integrate these studies with dynamic biochemical and imaging analysis of PC structure and function.
We believe that disclosing a novel role for Nbs1 on PC and SHH pathway may provide new insights into different genetic diseases affecting cerebellar development and cancer.

ERC
LS3_5, LS3_9, LS1_3
Keywords:
BASI BIOLOGICHE DEL CANCRO, GENETICA MOLECOLARE, GENETICA DELLO SVILUPPO, ORGANISMI GENETICAMENTE MODIFICATI, MEDICINA MOLECOLARE

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma